Neurocrine Biosciences Inc.'s Phase II data for its NBI-74788 – a corticotropin-releasing factor type 1 (CRF1) receptor antagonist – in adults with classic congenital adrenal hyperplasia (CAH) managed to beat that of competing start-up Spruce Biosciences to the punch.
The orphan disease is associated with lack of the stress hormone cortisol and overproduction of androgens. Overproduction of androgens can...







![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)